納洛酮與醒腦靜聯(lián)合搶救COPD并Ⅱ型呼吸衰竭的臨床觀察
發(fā)布時(shí)間:2018-08-26 20:24
【摘要】:目的探討納洛酮與醒腦靜聯(lián)合搶救慢性阻塞性肺部疾病(COPD)并Ⅱ型呼吸衰竭的臨床觀察。方法將314例COPD并Ⅱ型呼吸衰竭患者隨機(jī)分為兩組,治療組與對(duì)照組。治療組162例,用納洛酮聯(lián)合醒腦靜治療,對(duì)照組152例用常規(guī)方法治療。結(jié)果治療組總有效率為96.3%,對(duì)照組總有效率為94.1%,兩組差異有統(tǒng)計(jì)學(xué)意義(P0.05)。動(dòng)脈血?dú)夥治鼋Y(jié)果表明動(dòng)脈血氧分壓(PaO2)在干預(yù)后,治療組的結(jié)果明顯高于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05),而動(dòng)脈血二氧化碳分壓(PaCO2)的情況低于對(duì)照組,但差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論納洛酮與醒腦靜聯(lián)合治療性阻塞性肺氣腫并Ⅱ型呼吸衰竭臨床療效確切。
[Abstract]:Objective to investigate the clinical effect of naloxone combined with Xingnaojing in the treatment of chronic obstructive pulmonary disease (COPD) with type 鈪,
本文編號(hào):2206057
[Abstract]:Objective to investigate the clinical effect of naloxone combined with Xingnaojing in the treatment of chronic obstructive pulmonary disease (COPD) with type 鈪,
本文編號(hào):2206057
本文鏈接:http://sikaile.net/yixuelunwen/huxijib/2206057.html
最近更新
教材專著